APA (7th ed.) Citation

Drilon, A., Camidge, D. R., Lin, J. J., Kim, S., Solomon, B. J., Dziadziuszko, R., . . . Dooms, C. (2024). Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer. New England Journal of Medicine, 390(2), 118. https://doi.org/10.1056/NEJMoa2302299

Chicago Style (17th ed.) Citation

Drilon, A., et al. "Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer." New England Journal of Medicine 390, no. 2 (2024): 118. https://doi.org/10.1056/NEJMoa2302299.

MLA (9th ed.) Citation

Drilon, A., et al. "Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer." New England Journal of Medicine, vol. 390, no. 2, 2024, p. 118, https://doi.org/10.1056/NEJMoa2302299.